These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31462089)

  • 1. Plaque Calcification: Do Lipoproteins Have a Role?
    Akers EJ; Nicholls SJ; Di Bartolo BA
    Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):1902-1910. PubMed ID: 31462089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherosclerosis Calcification: Focus on Lipoproteins.
    Neels JG; Leftheriotis G; Chinetti G
    Metabolites; 2023 Mar; 13(3):. PubMed ID: 36984897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zooming in on the genesis of atherosclerotic plaque microcalcifications.
    Ruiz JL; Weinbaum S; Aikawa E; Hutcheson JD
    J Physiol; 2016 Jun; 594(11):2915-27. PubMed ID: 27040360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherosclerotic plaque regression: fact or fiction?
    Shanmugam N; Román-Rego A; Ong P; Kaski JC
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):311-7. PubMed ID: 20549322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial.
    Sabatine MS; Giugliano RP; Keech A; Honarpour N; Wang H; Liu T; Wasserman SM; Scott R; Sever PS; Pedersen TR
    Am Heart J; 2016 Mar; 173():94-101. PubMed ID: 26920601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone therapy, lipoprotein subclasses, and coronary calcification: the Healthy Women Study.
    Mackey RH; Kuller LH; Sutton-Tyrrell K; Evans RW; Holubkov R; Matthews KA
    Arch Intern Med; 2005 Mar; 165(5):510-5. PubMed ID: 15767525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-based statins and advanced carotid plaque: Role of CD163 positive macrophages in lipoprotein-associated phospholipase A
    Otsuka F; Zhao X; Trout HH; Qiao Y; Wasserman BA; Nakano M; Macphee CH; Brandt M; Krug-Gourley S; Guo L; Ladich ER; Cheng Q; Davis HR; Finn AV; Virmani R; Kolodgie FD
    Atherosclerosis; 2017 Dec; 267():78-89. PubMed ID: 29101839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
    Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
    JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein(a) phenotype determines the correlations of lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 levels in patients with potential familial hypercholesterolemia.
    Afanasieva OI; Ezhov MV; Razova OA; Afanasieva MI; Utkina EA; Pokrovsky SN
    Atherosclerosis; 2018 Oct; 277():477-482. PubMed ID: 30270088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vascular Calcification - Pathological Mechanism and Clinical Application - . The significance of arterial calcification in unstable plaques].
    Inaba M; Ueda M
    Clin Calcium; 2015 May; 25(5):679-86. PubMed ID: 25926571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCSK9 in relation to coronary plaque inflammation: Results of the ATHEROREMO-IVUS study.
    Cheng JM; Oemrawsingh RM; Garcia-Garcia HM; Boersma E; van Geuns RJ; Serruys PW; Kardys I; Akkerhuis KM
    Atherosclerosis; 2016 May; 248():117-22. PubMed ID: 27015246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.
    Urban D; Pöss J; Böhm M; Laufs U
    J Am Coll Cardiol; 2013 Oct; 62(16):1401-8. PubMed ID: 23973703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of Lp-PLA2 in lipid-lowering therapy.
    Racherla S; Arora R
    Am J Ther; 2012 Mar; 19(2):115-20. PubMed ID: 20634673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Evolocumab on Coronary Plaque Composition.
    Nicholls SJ; Puri R; Anderson T; Ballantyne CM; Cho L; Kastelein JJP; Koenig W; Somaratne R; Kassahun H; Yang J; Wasserman SM; Honda S; Shishikura D; Scherer DJ; Borgman M; Brennan DM; Wolski K; Nissen SE
    J Am Coll Cardiol; 2018 Oct; 72(17):2012-2021. PubMed ID: 30336824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Intensive Statin Therapy on Coronary High-Intensity Plaques Detected by Noncontrast T1-Weighted Imaging: The AQUAMARINE Pilot Study.
    Noguchi T; Tanaka A; Kawasaki T; Goto Y; Morita Y; Asaumi Y; Nakao K; Fujiwara R; Nishimura K; Miyamoto Y; Ishihara M; Ogawa H; Koga N; Narula J; Yasuda S
    J Am Coll Cardiol; 2015 Jul; 66(3):245-256. PubMed ID: 26184618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosensing of arteriosclerotic nanoplaque formation and interaction with an HMG-CoA reductase inhibitor.
    Abletshauser C; Klüssendorf D; Schmidt A; Winkler K; März W; Buddecke E; Malmsten M; Siegel G
    Acta Physiol Scand; 2002 Oct; 176(2):131-45. PubMed ID: 12354173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: an analysis from the LDL-C Assessment with Proprotein Convertase Subtilisin Kexin Type 9 Monoclonal Antibody Inhibition Combined with Statin Therapy (LAPLACE)-Thrombolysis in Myocardial Infarction (TIMI) 57 trial.
    Desai NR; Kohli P; Giugliano RP; O'Donoghue ML; Somaratne R; Zhou J; Hoffman EB; Huang F; Rogers WJ; Wasserman SM; Scott R; Sabatine MS
    Circulation; 2013 Aug; 128(9):962-9. PubMed ID: 23884353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein subclasses and coronary artery calcium in postmenopausal women from the healthy women study.
    Mackey RH; Kuller LH; Sutton-Tyrrell K; Evans RW; Holubkov R; Matthews KA
    Am J Cardiol; 2002 Oct; 90(8A):71i-76i. PubMed ID: 12419483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.